https://www.selleckchem.com/products/U0126.html
Open Access. Some rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO license (https//creativecommons.org/licenses/by-nc-sa/3.0/igo).OBJECTIVE We evaluated the beneficial effect of miR-20a mimic against diabetic angiopathy (DA) in rats by regulating intracellular antioxidant enzymes and vascular endothelial growth factor (VEGF). MATERIALS AND METHODS Diabetes was induced by intraperitoneal administration of streptozotocin (STZ; 65 mg/kg). Rats were then treated with miR-20a mimic (250 nmol/kg orally) for 8 weeks after ST
Like
Comment
Share
